VCI Wealth Management LLC Purchases New Position in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

VCI Wealth Management LLC purchased a new stake in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) during the 4th quarter, Holdings Channel reports. The fund purchased 12,365 shares of the company’s stock, valued at approximately $515,000.

A number of other institutional investors have also recently added to or reduced their stakes in XPH. Raymond James & Associates raised its holdings in SPDR S&P Pharmaceuticals ETF by 29.5% during the third quarter. Raymond James & Associates now owns 12,576 shares of the company’s stock worth $500,000 after buying an additional 2,863 shares during the last quarter. LPL Financial LLC boosted its position in SPDR S&P Pharmaceuticals ETF by 26.4% during the third quarter. LPL Financial LLC now owns 124,782 shares of the company’s stock worth $4,960,000 after purchasing an additional 26,031 shares during the period. Janney Montgomery Scott LLC lifted its holdings in shares of SPDR S&P Pharmaceuticals ETF by 9.4% in the third quarter. Janney Montgomery Scott LLC now owns 5,835 shares of the company’s stock worth $232,000 after buying an additional 500 shares in the last quarter. NBC Securities Inc. purchased a new stake in shares of SPDR S&P Pharmaceuticals ETF in the third quarter worth about $93,000. Finally, Ieq Capital LLC purchased a new stake in shares of SPDR S&P Pharmaceuticals ETF in the third quarter worth about $550,000.

SPDR S&P Pharmaceuticals ETF Stock Performance

XPH traded down $0.41 on Thursday, reaching $39.09. The company had a trading volume of 47,131 shares, compared to its average volume of 42,935. The business has a 50 day simple moving average of $42.61 and a 200 day simple moving average of $40.58. The company has a market cap of $191.54 million, a price-to-earnings ratio of 14.45 and a beta of 0.87. SPDR S&P Pharmaceuticals ETF has a 52-week low of $34.67 and a 52-week high of $45.62.

SPDR S&P Pharmaceuticals ETF Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.